1083 studies found for:    Open Studies | "HIV Infections"
Show Display Options
Rank Status Study
21 Recruiting Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: HIV Infection;   Recurrent Anal Cancer;   Recurrent Breast Cancer;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Anal Cancer;   Stage IV Breast Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Drug: carboplatin;   Drug: paclitaxel
22 Unknown  Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome;   HIV Infections
Interventions: Drug: first line ARV (3TC+NVP+D4T or 3TC+NVP+AZT);   Drug: second line ARV therapy (3TC+TDF+LPV/RTV)
23 Recruiting A Safety and Immune Response Study of 2 Experimental HIV Vaccines
Condition: HIV Infection
Interventions: Biological: ALVAC-HIV;   Biological: Bivalent Subtype C gp120/MF59®;   Biological: ALVAC-HIV (vCP2438) Placebo;   Biological: Bivalent gp120/MF59® Placebo
24 Recruiting A Long-term Follow-up of the HIV-NAT Cohort
Condition: HIV Infections
Intervention:
25 Recruiting Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?
Conditions: HIV Infection;   Herpes Simplex Type II;   HIV Infections
Interventions: Drug: valacyclovir;   Drug: Placebo
26 Recruiting Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection
Conditions: Human Immunodeficiency Virus;   HIV;   Vertical Infection Transmission
Intervention:
27 Recruiting Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy
Conditions: Acquired Immune Deficiency Syndrome Virus;   Acquired Immunodeficiency Syndrome Virus;   AIDS Virus;   Human Immunodeficiency Virus;   Human Immunodeficiency Viruses
Intervention:
28 Unknown  Injecting Drug Use Community Intervention Trial
Conditions: HIV;   Hepatitis C;   Syphilis;   HSV-2;   HIV Infections
Intervention: Behavioral: Intervention
29 Unknown  Pharmacotherapy for HIV+ Stimulant Dependent Individuals
Conditions: HIV Infections;   Cocaine Dependence
Intervention: Drug: ondansetron
30 Unknown  HIV-HBV Co-Infection and Liver Disease
Conditions: HIV Infections;   HIV-HBV Co-Infection
Intervention:
31 Unknown  Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women
Condition: HIV Infections
Interventions: Drug: Dapivirine;   Other: Placebo
32 Recruiting Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women
Condition: HIV Infections
Interventions: Drug: Dapivirine;   Drug: Placebo
33 Unknown  HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)
Condition: HIV Infections
Interventions: Drug: Pioglitazone;   Other: Observation
34 Unknown  Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
Condition: HIV Infections
Intervention:
35 Unknown  Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection
Condition: HIV Infections
Interventions: Drug: raltegravir (Isentress);   Drug: Truvada®
36 Recruiting Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
Conditions: Anal Squamous Cell Carcinoma;   HIV Infection;   Stage 0 Anal Canal Cancer;   Stage I Anal Canal Cancer
Intervention: Procedure: Therapeutic Conventional Surgery
37 Unknown  Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 2;   Drug: Placebo
38 Unknown  Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 1;   Drug: Placebo
39 Recruiting Early Antiviral Therapy for Critically Ill HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: early HAART;   Drug: Late HAART
40 Recruiting Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine Users
Condition: HIV Infections
Interventions: Behavioral: HIV Testing and Counseling;   Behavioral: Contingency Management;   Behavioral: Strengths-based case management

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years